ABO Review Course to Be Conducted at 2012 ASOA Congress

Article

An American Board of Opticianry (ABO) Review Course will be offered at the upcoming 2012 American Society of Ophthalmic Administrators (ASOA), April 20-24 in Chicago, according to the organization. The course will be held on Friday, April 20 at McCormick Place West in Chicago.

Fairfax, VA - An American Board of Opticianry (ABO) Review Course will be offered at the upcoming 2012 American Society of Ophthalmic Administrators (ASOA), April 20-24 in Chicago, according to the organization. The course will be held on Friday, April 20 at McCormick Place West in Chicago.

Delivered for the first time during the 2011 ASOA Congress, the ABO Review Course complements the Optical Forum at the 2012 ASOA Congress. The 8-hour course will benefit opticians who are preparing for the ABO Certification examination.

“The ABO approved courses will allow certified opticians who attend the meeting to obtain all their hours in one place and at one time,” said Arthur De Gennaro, Optical Forum Program Chair, ASOA Congress. “By providing ABO accredited education, ASOA hopes to encourage administrators, opticians, and ophthalmologists to attend courses together. This will foster better operational and strategic planning for the dispensary.”

A separate course registration is available and attendees of this course do not need to register for the entire ASOA Congress. Registration is available at www.asoa.org.

For more articles in this issue of InDispensable, click here.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
Steven Ferrucci, OD, FAAO, at Controversies in Modern Eyecare 2025
© 2025 MJH Life Sciences

All rights reserved.